Novo Nordisk A/S annual shares outstanding for fiscal TTM was 4,449 million shares, an increase of 0.0% from 4,448 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Shares Outstanding (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 4,449M | 4,448M | 4,463M | 4,495M | 4,545M | 4,606M | 4,680M | 4,757M | 4,849M | 4,956M | 5,070M | 5,157M | 5,260M | 5,387M | 5,517M | 5,701M | 5,855M | 6,043M | 6,226M | 6,357M | 6,459M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Shares Outstanding (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 4,449M | 4,448M | 4,447M | 4,447M | 4,446M | 4,460M | 4,460M | 4,465M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NVO metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow
All NVO financial statements → Interactive NVO charts →
About TickerBase · Data methodology & sources